Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes

Cytochrome P450 (CYP) substrates that yield fluorescent metabolites were used for rapid screening of drug metabolism activities of 13 recombinant human cytochromes P450, human liver microsomes and human hepatocytes. Reproducible results were obtained using a fluorescent plate reader (CytoFluor) more...

Full description

Saved in:
Bibliographic Details
Published inBiopharmaceutics & drug disposition Vol. 24; no. 9; pp. 375 - 384
Main Authors Ghosal, Anima, Hapangama, Neil, Yuan, Yuan, Lu, Xiaowen, Horne, Debra, Patrick, James E., Zbaida, Shmuel
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.12.2003
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cytochrome P450 (CYP) substrates that yield fluorescent metabolites were used for rapid screening of drug metabolism activities of 13 recombinant human cytochromes P450, human liver microsomes and human hepatocytes. Reproducible results were obtained using a fluorescent plate reader (CytoFluor) more expediently than those generated using conventional HPLC methods. Typically, results for 96 samples were obtained with the plate reader in less than 10 min as opposed to 15–35 min/sample required by conventional HPLC. The fluorescent substrates used to measure CYP activities were as follows: 3‐cyano‐7‐ethoxycoumarin (CEC) for CYP1A1, CYP1A2, CYP2C9 and CYP2C19; 7‐ethoxyresorufin (7‐ER) for CYP1A1, CYP1A2 and CYP1B1; 3‐[2‐(N,N‐diethyl‐N‐methylammonium)ethyl]‐7‐methoxy‐4‐methylcoumarin (AMMC) for CYP2D6; dibenzylfluorescein (DBF) for CYP3A4, CYP3A5 and CYP2C8; 7‐methoxy‐4‐trifluoromethylcoumarin (7‐MFC) for CYP2E1, CYP2B6 and CYP2C18; and coumarin for CYP2A6. The chemical inhibition and correlation data indicated that the following substrates can be used as specific functional probes for individual cytochrome P450 present in human liver microsomes: coumarin for CYP2A6 (r=0.82), AMMC for CYP2D6 (r=0.83) and DBF for CYP3A4 (r=0.92). The fluorescent plate reader was found to be useful for the rapid assessment of CYP activities (positive control) in both intact cells and subcellular fractions. Copyright © 2003 John Wiley & Sons, Ltd.
AbstractList Cytochrome P450 (CYP) substrates that yield fluorescent metabolites were used for rapid screening of drug metabolism activities of 13 recombinant human cytochromes P450, human liver microsomes and human hepatocytes. Reproducible results were obtained using a fluorescent plate reader (CytoFluor) more expediently than those generated using conventional HPLC methods. Typically, results for 96 samples were obtained with the plate reader in less than 10 min as opposed to 15-35 min/sample required by conventional HPLC. The fluorescent substrates used to measure CYP activities were as follows: 3-cyano-7-ethoxycoumarin (CEC) for CYP1A1, CYP1A2, CYP2C9 and CYP2C19; 7-ethoxyresorufin (7-ER) for CYP1A1, CYP1A2 and CYP1B1; 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) for CYP2D6; dibenzylfluorescein (DBF) for CYP3A4, CYP3A5 and CYP2C8; 7-methoxy-4-trifluoromethylcoumarin (7-MFC) for CYP2E1, CYP2B6 and CYP2C18; and coumarin for CYP2A6. The chemical inhibition and correlation data indicated that the following substrates can be used as specific functional probes for individual cytochrome P450 present in human liver microsomes: coumarin for CYP2A6 (r=0.82), AMMC for CYP2D6 (r=0.83) and DBF for CYP3A4 (r=0.92). The fluorescent plate reader was found to be useful for the rapid assessment of CYP activities (positive control) in both intact cells and subcellular fractions.
Cytochrome P450 (CYP) substrates that yield fluorescent metabolites were used for rapid screening of drug metabolism activities of 13 recombinant human cytochromes P450, human liver microsomes and human hepatocytes. Reproducible results were obtained using a fluorescent plate reader (CytoFluor) more expediently than those generated using conventional HPLC methods. Typically, results for 96 samples were obtained with the plate reader in less than 10 min as opposed to 15–35 min/sample required by conventional HPLC. The fluorescent substrates used to measure CYP activities were as follows: 3‐cyano‐7‐ethoxycoumarin (CEC) for CYP1A1, CYP1A2, CYP2C9 and CYP2C19; 7‐ethoxyresorufin (7‐ER) for CYP1A1, CYP1A2 and CYP1B1; 3‐[2‐(N,N‐diethyl‐N‐methylammonium)ethyl]‐7‐methoxy‐4‐methylcoumarin (AMMC) for CYP2D6; dibenzylfluorescein (DBF) for CYP3A4, CYP3A5 and CYP2C8; 7‐methoxy‐4‐trifluoromethylcoumarin (7‐MFC) for CYP2E1, CYP2B6 and CYP2C18; and coumarin for CYP2A6. The chemical inhibition and correlation data indicated that the following substrates can be used as specific functional probes for individual cytochrome P450 present in human liver microsomes: coumarin for CYP2A6 (r=0.82), AMMC for CYP2D6 (r=0.83) and DBF for CYP3A4 (r=0.92). The fluorescent plate reader was found to be useful for the rapid assessment of CYP activities (positive control) in both intact cells and subcellular fractions. Copyright © 2003 John Wiley & Sons, Ltd.
Abstract Cytochrome P450 (CYP) substrates that yield fluorescent metabolites were used for rapid screening of drug metabolism activities of 13 recombinant human cytochromes P450, human liver microsomes and human hepatocytes. Reproducible results were obtained using a fluorescent plate reader (CytoFluor) more expediently than those generated using conventional HPLC methods. Typically, results for 96 samples were obtained with the plate reader in less than 10 min as opposed to 15–35 min/sample required by conventional HPLC. The fluorescent substrates used to measure CYP activities were as follows: 3‐cyano‐7‐ethoxycoumarin (CEC) for CYP1A1, CYP1A2, CYP2C9 and CYP2C19; 7‐ethoxyresorufin (7‐ER) for CYP1A1, CYP1A2 and CYP1B1; 3‐[2‐( N , N ‐diethyl‐ N ‐methylammonium)ethyl]‐7‐methoxy‐4‐methylcoumarin (AMMC) for CYP2D6; dibenzylfluorescein (DBF) for CYP3A4, CYP3A5 and CYP2C8; 7‐methoxy‐4‐trifluoromethylcoumarin (7‐MFC) for CYP2E1, CYP2B6 and CYP2C18; and coumarin for CYP2A6. The chemical inhibition and correlation data indicated that the following substrates can be used as specific functional probes for individual cytochrome P450 present in human liver microsomes: coumarin for CYP2A6 ( r =0.82), AMMC for CYP2D6 ( r =0.83) and DBF for CYP3A4 ( r =0.92). The fluorescent plate reader was found to be useful for the rapid assessment of CYP activities (positive control) in both intact cells and subcellular fractions. Copyright © 2003 John Wiley & Sons, Ltd.
Author Zbaida, Shmuel
Yuan, Yuan
Ghosal, Anima
Horne, Debra
Hapangama, Neil
Patrick, James E.
Lu, Xiaowen
Author_xml – sequence: 1
  givenname: Anima
  surname: Ghosal
  fullname: Ghosal, Anima
  email: anima.ghosal@spcorp.com
  organization: Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, New Jersey, USA
– sequence: 2
  givenname: Neil
  surname: Hapangama
  fullname: Hapangama, Neil
  organization: Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, New Jersey, USA
– sequence: 3
  givenname: Yuan
  surname: Yuan
  fullname: Yuan, Yuan
  organization: Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, New Jersey, USA
– sequence: 4
  givenname: Xiaowen
  surname: Lu
  fullname: Lu, Xiaowen
  organization: Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, New Jersey, USA
– sequence: 5
  givenname: Debra
  surname: Horne
  fullname: Horne, Debra
  organization: Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, New Jersey, USA
– sequence: 6
  givenname: James E.
  surname: Patrick
  fullname: Patrick, James E.
  organization: Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, New Jersey, USA
– sequence: 7
  givenname: Shmuel
  surname: Zbaida
  fullname: Zbaida, Shmuel
  organization: Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, New Jersey, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15366614$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/14689466$$D View this record in MEDLINE/PubMed
BookMark eNp10M1u1DAUBWALtaLTgngDlA2wgBTfxLGTZZmWtmoFqKqgYmP550ZjSJzBzkwJT0-mieiKlaXrT-fa55Ds-c4jIS-AHgOl2Xtt7XEu2BOyAFpVKS3hbo8sKLAszUSZHZDDGH9QSjkAPCUHwHhZMc4XZHuj1s4mFnsMrfOqd51PujpB_2doMVGmd1vXO4y7YUDTtXpUvk9Wm1b5xAx9Z1aha0fwhRX03Txv3BZD0joTuvhwqbxNVrhWIx96jM_Ifq2aiM_n84jcfjy7XV6k15_PL5cn16lhTLCUc67BcstA5yXXVYEKDChqLaNocqqF0VXJwJac2TpHEHUNtBRFVmpd2fyIvJ5i16H7tcHYy9ZFg02jPHabKAUwAQXnI3wzwd2DY8BaroNrVRgkULlrWI4Ny7HhUb6cIze6Rfvo5kpH8GoGKhrV1EF54-KjK_LxV7ALeju5e9fg8L998sPp6bQ2nbSLPf7-p1X4KbnIRSG_fTqXV3ffaX7zdSkv8r8xJqPg
CODEN BDDID8
CitedBy_id crossref_primary_10_1016_j_aquatox_2011_10_016
crossref_primary_10_1016_j_taap_2017_09_023
crossref_primary_10_1124_pr_115_011411
crossref_primary_10_1038_nchembio734
crossref_primary_10_1016_j_ccr_2020_213600
crossref_primary_10_1016_j_chroma_2008_05_080
crossref_primary_10_1002_med_21273
crossref_primary_10_1080_13880200600746196
crossref_primary_10_1007_s00216_008_2248_9
crossref_primary_10_1371_journal_pone_0086230
crossref_primary_10_1248_jhs_56_239
crossref_primary_10_1002_ptr_3371
crossref_primary_10_1016_j_ejps_2019_02_016
crossref_primary_10_1021_acsbiomaterials_0c01311
crossref_primary_10_1016_j_aquatox_2010_01_005
crossref_primary_10_1016_j_abb_2007_02_014
crossref_primary_10_1177_1087057107301496
crossref_primary_10_1016_j_diff_2008_10_008
crossref_primary_10_1007_s11418_013_0794_8
crossref_primary_10_1016_j_apsb_2022_01_009
crossref_primary_10_1124_dmd_111_042820
crossref_primary_10_1002_jcc_21190
crossref_primary_10_1021_np800098f
crossref_primary_10_1124_dmd_109_031054
crossref_primary_10_1124_dmd_106_014472
crossref_primary_10_1016_j_crtox_2023_100116
crossref_primary_10_1124_dmd_122_000900
crossref_primary_10_1016_j_bcp_2005_01_007
crossref_primary_10_1016_j_dmpk_2022_100451
crossref_primary_10_1124_dmd_107_017517
crossref_primary_10_1155_2015_321820
crossref_primary_10_1186_s12302_024_00913_w
crossref_primary_10_1124_dmd_110_036996
crossref_primary_10_1124_jpet_106_102921
crossref_primary_10_1042_BCJ20190532
crossref_primary_10_1007_s10565_006_0055_7
crossref_primary_10_1016_j_bmcl_2008_06_015
crossref_primary_10_3390_genes13111977
crossref_primary_10_1039_C5RA26736F
crossref_primary_10_3109_00498251003786749
crossref_primary_10_1016_j_jep_2009_07_036
crossref_primary_10_1016_j_tiv_2007_03_022
crossref_primary_10_2217_pgs_15_42
crossref_primary_10_1002_bit_22270
crossref_primary_10_1002_med_21982
crossref_primary_10_1021_jm900201b
crossref_primary_10_1016_j_abb_2006_10_018
crossref_primary_10_1016_j_freeradbiomed_2006_06_017
crossref_primary_10_1016_j_jep_2010_01_039
crossref_primary_10_1080_00498250500136569
crossref_primary_10_1016_j_taap_2022_116258
crossref_primary_10_1093_toxsci_kfw031
crossref_primary_10_1124_dmd_122_001068
crossref_primary_10_1016_j_cbi_2014_12_025
crossref_primary_10_1016_j_jpba_2005_07_002
crossref_primary_10_1007_s00210_019_01651_0
crossref_primary_10_3390_biomedicines6040106
crossref_primary_10_1080_00498254_2018_1530399
crossref_primary_10_1016_j_trac_2022_116791
crossref_primary_10_1080_00498254_2018_1483543
Cites_doi 10.1006/abio.1999.4348
10.1097/00008571-199602000-00002
10.1124/dmd.30.7.845
10.1006/abio.1993.1381
10.1006/abio.1997.2145
10.1016/S0021-9258(18)32132-X
ContentType Journal Article
Copyright Copyright © 2003 John Wiley & Sons, Ltd.
2004 INIST-CNRS
Copyright 2003 John Wiley & Sons, Ltd.
Copyright_xml – notice: Copyright © 2003 John Wiley & Sons, Ltd.
– notice: 2004 INIST-CNRS
– notice: Copyright 2003 John Wiley & Sons, Ltd.
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/bdd.374
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1099-081X
EndPage 384
ExternalDocumentID 10_1002_bdd_374
14689466
15366614
BDD374
ark_67375_WNG_KXZ03RVC_H
Genre article
Journal Article
Comparative Study
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23N
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAJUZ
AANLZ
AAONW
AASGY
AAVGM
AAXRX
AAZKR
ABCQN
ABCUV
ABCVL
ABEML
ABHUG
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFVGU
AFZJQ
AGJLS
AHBTC
AHMBA
AI.
AIACR
AIAGR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
GWYGA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
M6Q
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
V8K
VH1
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWP
WXI
WXSBR
XG1
XPP
XV2
YCJ
ZZTAW
~IA
~WT
AITYG
HGLYW
AAPBV
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4474-666b1d6d41b386b95ea1c1a0dd40ec30b7cb9841d864df3e17ff1087528bb9d3
IEDL.DBID DR2
ISSN 0142-2782
IngestDate Sat Aug 17 01:15:31 EDT 2024
Fri Aug 23 01:47:54 EDT 2024
Sat Sep 28 07:40:37 EDT 2024
Sun Oct 22 16:09:02 EDT 2023
Sat Aug 24 00:54:00 EDT 2024
Wed Jan 17 05:00:28 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Human
human liver microsomes
Enzyme
Isozyme
Cytochrome P450
Liver
Microsome
In vitro
fluorescent probes
Enzymatic activity
Hepatocyte
Drug-metabolizing enzyme
Recombinant protein
Language English
License CC BY 4.0
Copyright 2003 John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4474-666b1d6d41b386b95ea1c1a0dd40ec30b7cb9841d864df3e17ff1087528bb9d3
Notes ark:/67375/WNG-KXZ03RVC-H
ArticleID:BDD374
istex:6C62564E7175648DC86BAC62CDE79EB25AD9595D
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 14689466
PQID 71471566
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_71471566
crossref_primary_10_1002_bdd_374
pubmed_primary_14689466
pascalfrancis_primary_15366614
wiley_primary_10_1002_bdd_374_BDD374
istex_primary_ark_67375_WNG_KXZ03RVC_H
PublicationCentury 2000
PublicationDate December 2003
PublicationDateYYYYMMDD 2003-12-01
PublicationDate_xml – month: 12
  year: 2003
  text: December 2003
PublicationDecade 2000
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: Chichester
– name: England
PublicationTitle Biopharmaceutics & drug disposition
PublicationTitleAlternate Biopharm. Drug Dispos
PublicationYear 2003
Publisher John Wiley & Sons, Ltd
Wiley
Publisher_xml – name: John Wiley & Sons, Ltd
– name: Wiley
References Crespi CL. Higher-throughput screening with human cytochromes P450. Curr Opin Drug Discovery Develop 1999; 2: 15-19.
Ghosal A, Hapangama N, Yuan Y, Patrick JE, Cayen MN, Zbaida S. Microtiter plate based assay for a rapid determination of enzyme activities of 13 P450 supersomes and human liver microsomes Abstract 103. 10th North American ISSX Meeting, Indianapolis, 2000. Drug Metabolism Review 32: 188.
Kronbach DM, Umeno M, Gonzalez FJ, Meyer UA. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 1989; 36: 89-96.
Donato MT, Gomez-Lechon MJ, Castell JV. A microassay for measuring cytochrome P4501A1 and P450IIBI activities in intact human and rat hepatocytes cultured on 96-well plates. Anal Biochem 1993; 213: 29-33.
Shimada T, Gillam EMJ, Sutter TR, Strickland PT, Guengerich FP, Yamazaki H. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab Dispos 1997; 29: 617-622.
Tang C, Shou M, Rodrigues AD. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity. Drug Metab Dispos 2000; 28: 567-572.
Masimirembwa CM, Otter C, Berg M, et al. Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research. Drug Metab Dispos 1999; 27: 1117-1122.
Wood AW, Ryan DE, Thomas PE, Levin W. Regio- and stereoselective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P450 isozymes. J Biol Chem 1983; 258: 8839-8847.
Chauret N, Tremblay N, Lackman RL, et al. Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a select fluorescent probe. Anal Biochem 1999; 276: 215-226.
Nelson DR, Koymans L, Kamataki T, et al. P450 superfamily; update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1-42.
Chauret N, Gauthier A, Martin J, Nicoll-Griffth DA. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat and horse. Drug Metab Dispos 1997; 25: 1130-1136.
Bapiro TE, Egnell A-C, Hasler JA, Masimirembwa CM. Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos 2001; 29: 30-35.
Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL. Cytochrome P450 fluorometric substrates: Identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos 2002; 30: 845-852.
Crespi CL, Miller VPand Penman BW. Microtiter plate assays for the inhibition of human, drug-metabolizing cytochromes P450. Anal Biochem 1997; 248: 188-190.
Chauret N, Dobbs B, Lackman RL, et al. The use of 3-[2-( N, N-diethyl- N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes. Drug Metab Dispos 2001; 29: 1196-1200.
1983; 258
1997; 248
2000; 28
2002; 30
2000; 32
1997; 25
1999; 27
1997; 29
1999; 2
1999; 276
2001; 29
1993; 213
1989; 36
1996; 6
Chauret N (e_1_2_1_15_2) 2001; 29
Wood AW (e_1_2_1_5_2) 1983; 258
Crespi CL (e_1_2_1_3_2) 1999; 2
Masimirembwa CM (e_1_2_1_16_2) 1999; 27
Bapiro TE (e_1_2_1_9_2) 2001; 29
Chauret N (e_1_2_1_11_2) 1997; 25
e_1_2_1_6_2
e_1_2_1_7_2
Shimada T (e_1_2_1_10_2) 1997; 29
Ghosal A (e_1_2_1_13_2) 2000; 32
e_1_2_1_2_2
Tang C (e_1_2_1_14_2) 2000; 28
e_1_2_1_12_2
Kronbach DM (e_1_2_1_4_2) 1989; 36
e_1_2_1_8_2
References_xml – volume: 28
  start-page: 567
  year: 2000
  end-page: 572
  article-title: Substrate‐dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity
  publication-title: Drug Metab Dispos
– volume: 29
  start-page: 617
  year: 1997
  end-page: 622
  article-title: Oxidation of xenobiotics by recombinant human cytochrome P450 1B1
  publication-title: Drug Metab Dispos
– volume: 30
  start-page: 845
  year: 2002
  end-page: 852
  article-title: Cytochrome P450 fluorometric substrates: Identification of isoform‐selective probes for rat CYP2D2 and human CYP3A4
  publication-title: Drug Metab Dispos
– volume: 2
  start-page: 15
  year: 1999
  end-page: 19
  article-title: Higher‐throughput screening with human cytochromes P450
  publication-title: Curr Opin Drug Discovery Develop
– volume: 36
  start-page: 89
  year: 1989
  end-page: 96
  article-title: Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4
  publication-title: Mol Pharmacol
– volume: 27
  start-page: 1117
  year: 1999
  end-page: 1122
  article-title: Heterologous expression and kinetic characterization of human cytochromes P‐450: validation of a pharmaceutical tool for drug metabolism research
  publication-title: Drug Metab Dispos
– volume: 6
  start-page: 1
  year: 1996
  end-page: 42
  article-title: P450 superfamily; update on new sequences, gene mapping, accession numbers and nomenclature
  publication-title: Pharmacogenetics
– volume: 213
  start-page: 29
  year: 1993
  end-page: 33
  article-title: A microassay for measuring cytochrome P4501A1 and P450IIBI activities in intact human and rat hepatocytes cultured on 96‐well plates
  publication-title: Anal Biochem
– volume: 29
  start-page: 30
  year: 2001
  end-page: 35
  article-title: Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s
  publication-title: Drug Metab Dispos
– volume: 258
  start-page: 8839
  year: 1983
  end-page: 8847
  article-title: Regio‐ and stereoselective metabolism of two C steroids by five highly purified and reconstituted rat hepatic cytochrome P450 isozymes
  publication-title: J Biol Chem
– volume: 248
  start-page: 188
  year: 1997
  end-page: 190
  article-title: Microtiter plate assays for the inhibition of human, drug‐metabolizing cytochromes P450
  publication-title: Anal Biochem
– volume: 276
  start-page: 215
  year: 1999
  end-page: 226
  article-title: Description of a 96‐well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a select fluorescent probe
  publication-title: Anal Biochem
– volume: 25
  start-page: 1130
  year: 1997
  end-page: 1136
  article-title: In vitro comparison of cytochrome P450‐mediated metabolic activities in human, dog, cat and horse
  publication-title: Drug Metab Dispos
– volume: 32
  start-page: 188
  year: 2000
  article-title: Microtiter plate based assay for a rapid determination of enzyme activities of 13 P450 supersomes and human liver microsomes Abstract 103. 10th North American ISSX Meeting, Indianapolis
  publication-title: Drug Metabolism Review
– volume: 29
  start-page: 1196
  year: 2001
  end-page: 1200
  article-title: The use of 3‐[2‐( , ‐diethyl‐ ‐methylammonium)ethyl]‐7‐methoxy‐4‐methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes
  publication-title: Drug Metab Dispos
– ident: e_1_2_1_7_2
  doi: 10.1006/abio.1999.4348
– volume: 25
  start-page: 1130
  year: 1997
  ident: e_1_2_1_11_2
  article-title: In vitro comparison of cytochrome P450‐mediated metabolic activities in human, dog, cat and horse
  publication-title: Drug Metab Dispos
  contributor:
    fullname: Chauret N
– volume: 32
  start-page: 188
  year: 2000
  ident: e_1_2_1_13_2
  article-title: Microtiter plate based assay for a rapid determination of enzyme activities of 13 P450 supersomes and human liver microsomes Abstract 103. 10th North American ISSX Meeting, Indianapolis
  publication-title: Drug Metabolism Review
  contributor:
    fullname: Ghosal A
– volume: 28
  start-page: 567
  year: 2000
  ident: e_1_2_1_14_2
  article-title: Substrate‐dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity
  publication-title: Drug Metab Dispos
  contributor:
    fullname: Tang C
– volume: 27
  start-page: 1117
  year: 1999
  ident: e_1_2_1_16_2
  article-title: Heterologous expression and kinetic characterization of human cytochromes P‐450: validation of a pharmaceutical tool for drug metabolism research
  publication-title: Drug Metab Dispos
  contributor:
    fullname: Masimirembwa CM
– ident: e_1_2_1_2_2
  doi: 10.1097/00008571-199602000-00002
– ident: e_1_2_1_12_2
  doi: 10.1124/dmd.30.7.845
– volume: 29
  start-page: 30
  year: 2001
  ident: e_1_2_1_9_2
  article-title: Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s
  publication-title: Drug Metab Dispos
  contributor:
    fullname: Bapiro TE
– volume: 2
  start-page: 15
  year: 1999
  ident: e_1_2_1_3_2
  article-title: Higher‐throughput screening with human cytochromes P450
  publication-title: Curr Opin Drug Discovery Develop
  contributor:
    fullname: Crespi CL
– volume: 29
  start-page: 617
  year: 1997
  ident: e_1_2_1_10_2
  article-title: Oxidation of xenobiotics by recombinant human cytochrome P450 1B1
  publication-title: Drug Metab Dispos
  contributor:
    fullname: Shimada T
– ident: e_1_2_1_6_2
  doi: 10.1006/abio.1993.1381
– volume: 29
  start-page: 1196
  year: 2001
  ident: e_1_2_1_15_2
  article-title: The use of 3‐[2‐( N, N‐diethyl‐ N‐methylammonium)ethyl]‐7‐methoxy‐4‐methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes
  publication-title: Drug Metab Dispos
  contributor:
    fullname: Chauret N
– volume: 36
  start-page: 89
  year: 1989
  ident: e_1_2_1_4_2
  article-title: Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4
  publication-title: Mol Pharmacol
  contributor:
    fullname: Kronbach DM
– ident: e_1_2_1_8_2
  doi: 10.1006/abio.1997.2145
– volume: 258
  start-page: 8839
  year: 1983
  ident: e_1_2_1_5_2
  article-title: Regio‐ and stereoselective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P450 isozymes
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)32132-X
  contributor:
    fullname: Wood AW
SSID ssj0006111
Score 1.9642608
Snippet Cytochrome P450 (CYP) substrates that yield fluorescent metabolites were used for rapid screening of drug metabolism activities of 13 recombinant human...
Abstract Cytochrome P450 (CYP) substrates that yield fluorescent metabolites were used for rapid screening of drug metabolism activities of 13 recombinant...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 375
SubjectTerms Analytical, structural and metabolic biochemistry
Biological and medical sciences
Cytochrome P-450 Enzyme System - chemistry
Cytochrome P-450 Enzyme System - metabolism
cytochrome P450
Enzymes and enzyme inhibitors
fluorescent probes
Fluorometry
Fundamental and applied biological sciences. Psychology
Hepatocytes - enzymology
human liver microsomes
Humans
In Vitro Techniques
Kinetics
Microsomes, Liver - enzymology
Oxidoreductases
Recombinant Proteins - chemistry
Recombinant Proteins - metabolism
Title Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes
URI https://api.istex.fr/ark:/67375/WNG-KXZ03RVC-H/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbdd.374
https://www.ncbi.nlm.nih.gov/pubmed/14689466
https://search.proquest.com/docview/71471566
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLbQduECjJ9hY_gw9dR0ceLEyXFsjArEVFUFql0sO3Y0NJpOSzst--t5z24XikBCnCL5R5TY7_l9Tj5_j5ADiOFKZ1UUVgwsmGvBQvAiEQqT2dLGEIScdufns2z4hX-cptNfUn15fYj7D27oGW69RgdXujnsREO1MYNEoBIoyughHBp3wlEZYz4ToTt8ksf-uCz2PFz124hD2zikt8iLVA0MTeVzWvwJdG5iWBeETh-T8_Xje-7J5WC50IPy7jdlx_96vyfk0Qqa0iNvSzvkga2fkt7Ia1u3fTrpjmo1fdqjo071un1Gbsbq6ruhZk2vwQmn84ra-q6dWYrnJ26ceisW4jZ8ph0Jh7osgbRsF_PyArUTGjriadRflf9A3gidIW2wcZWqNvQCYig0bwEmPyeT0_eT42G4SuoQlpwLHsJ2STOTGc50kme6SK1iJVORMTyyZRJpUeoi58zkGTdVYpmoKoay-3GudWGSF2Srntf2FaFFBeA2qQCBFShyE2ulbVqkRsPs47oUELqeYXnlpTukF2mOJQyuhMENSM_N_H29ur5EpptI5bezD_LT9DxKxl-P5TAg-xum0d0wTTKEOAF5u7YVCQ6Kf11UbefLRgoG8R9Ac0BeehPq-vIsR3n_gBw4Q_jbU8p3Jydwef1vzXbJQ084RMrNHtlaXC_tGwBOC73vfOQnwWwWLQ
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD6C7QFeuF_CZfPD1Kemixvn9ggbo7CtqqoCFTxYcexoaDSdlnai-_WcY6eLikBCPEVy7Ci2z8n57HznM8AexvBcxWXglxwtWKiE--hFiZ_o2BSmj0HIaneeDuPBJ_FxGk0bViXlwjh9iJsNN_IM-70mB6cN6f1WNVRp3QsTcRu20dkju5wat9JRMefuLEKbfpL2XcIsNd1vGm5Eom0a1J_EjMxrHJzSnWrxJ9i5iWJtGDq6D9_WHXDsk_PecqF6xfVv2o7_18MHcK9Bp-yNM6eHcMtUj6AzcvLWqy6btNladZd12KgVvl49hqtxfvFdM71m2NCcs3nJTHW9mhlGKRRXVsCVCmklPlOWh8PsQYGsWC3mxRnJJ9RsJKKg25T_IOoImxFzsLY380qzMwyjWH2FSPkJTI7eTQ4GfnOug18IkQgfV0yK61gLrsI0Vllkcl7wPNBaBKYIA5UUKksF12ksdBkanpQlJ-X9fqpUpsOnsFXNK_McWFYivg1LBGEZ6dz0Va5MlEVa4fTTp8kDtp5ieeHUO6TTae5LHFyJg-tBx079zf388pzIbkkkvwzfy-Pp1yAcfz6QAw92NmyjfWAUxoRyPNhdG4tEH6UfL3ll5staJhwhAOJmD545G2rbijglhX8P9qwl_O0t5dvDQ7y8-Ldqu3BnMDk9kScfhscv4a7jHxID5xVsLS6X5jXiqIXasQ7zCxqYGk8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD6CTUK8MK4jAzY_TH1qujhxbo-wUgqDqqoKVHux4tjW0Ghare1E9uvxsduFIpAQT5F8iRL7HJ_PyefvABybGF6IRAe-psaCmUipb7wo9VOZqFKFJghZ7c5Pg6T_mX2YxJNfUn05fYjbD27oGXa9RgefS33SiIYKKTtRyu7CLkuiEA26O2qUoxJKXSpCe_okC915Wex6su64FYh2cUx_IDGyWJix0S6pxZ9Q5zaItVGotwfnm-d35JPLzmopOuXNb9KO__WCD-HBGpuS186YHsEdVT2G1tCJW9dtMm7Oai3apEWGjex1_QSuR8X8myRyw6_BGSczTVR1U08VwQMU11a-FQtxHz4VloVDbJpAUtbLWXmB4gkLMmRx0F6Xf0fiCJkib3BhK4tKkgsTRE3z2uDkpzDuvR2f9v11Vge_ZCxlvtkvCSoTyaiIskTksSpoSYtAShaoMgpEWoo8Y1RmCZM6UjTVmqLufpgJkcvoGexUs0o9B5Jrg24jbSBYjio3oSiEivNYCjP7uDB5QDYzzOdOu4M7leaQm8HlZnA9aNmZv60vri6R6pbG_OvgHT-bnAfR6Msp73twuGUazQ3jKEGM48HRxla48VD87VJUarZa8JQaAGBQswf7zoSavizJUN_fg2NrCH97Sv6m2zWXg39rdgT3ht0e__h-cPYC7jvyIdJvXsLO8mqlXhkQtRSH1l1-AsQ2GP4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapid+determination+of+enzyme+activities+of+recombinant+human+cytochromes+P450%2C+human+liver+microsomes+and+hepatocytes&rft.jtitle=Biopharmaceutics+%26+drug+disposition&rft.au=GHOSAL%2C+Anima&rft.au=HAPANGAMA%2C+Neil&rft.au=YUAN+YUAN&rft.au=XIAOWEN+LU&rft.date=2003-12-01&rft.pub=Wiley&rft.issn=0142-2782&rft.eissn=1099-081X&rft.volume=24&rft.issue=9&rft.spage=375&rft.epage=384&rft_id=info:doi/10.1002%2Fbdd.374&rft.externalDBID=n%2Fa&rft.externalDocID=15366614
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0142-2782&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0142-2782&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0142-2782&client=summon